An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19

Clinical trial NCT04346693 · COMPLETED

Trial details

NCT number: NCT04346693
Sponsor: Burnasyan Federal Medical Biophysical Center
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Respiratory Tract Infection Acute Respiratory Insufficiency Pneumonia Septic Shock Hypoxemia

Start date: 2020-04-08
Primary completion: 2020-11-01
Enrollment: 320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.